Kolexia
Delmer Alain
Médecine générale
Hôpital Robert-Debré Reims
Reims, France
240 Activités
202 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Lymphomes Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde Lymphome folliculaire Macroglobulinémie de Waldenström Lymphome B diffus à grandes cellules Lymphome B Maladie de Hodgkin

Industries

Janssen
23 collaboration(s)
Dernière en 2023
AstraZeneca
16 collaboration(s)
Dernière en 2023
Abbvie
13 collaboration(s)
Dernière en 2023
Edimark
6 collaboration(s)
Dernière en 2021

Dernières activités

AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
Minimal Residual Disease-Guided Combination of Ibrutinib and Venetoclax Compared to FCR in Untreated Patients with CLL of Intermediate Risk : Interim Results of MRD Kinetics in the Eradic Trial from the Filo Group
65th ASH Annual Meeting Abstracts   02 novembre 2023
CD19-Targeting CAR T-Cell Therapy in Transformed Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Modified Staging System for Waldenström Macroglobulinemia (MSS-WM): A Multi-Institutional Externally Validated Prognostic Model for Active/Symptomatic Waldenström Macroglobulinemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Transformation histologique dans la macroglobulinémie de Waldenström : aspects cliniques, pronostiques et thérapeutiques
Edimark   01 septembre 2023
A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.
Blood advances   28 juillet 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial.
European journal of cancer (Oxford, England : 1990)   17 juillet 2023
Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance.
Diagnostics (Basel, Switzerland)   30 juin 2023
Autologous and allogeneic stem-cell transplantation for transformed Waldenström macroglobulinemia
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023